1. Home
  2. BEAM vs ALHC Comparison

BEAM vs ALHC Comparison

Compare BEAM & ALHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • ALHC
  • Stock Information
  • Founded
  • BEAM 2017
  • ALHC 2013
  • Country
  • BEAM United States
  • ALHC United States
  • Employees
  • BEAM N/A
  • ALHC N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • ALHC Medical Specialities
  • Sector
  • BEAM Health Care
  • ALHC Health Care
  • Exchange
  • BEAM Nasdaq
  • ALHC Nasdaq
  • Market Cap
  • BEAM 1.9B
  • ALHC 2.3B
  • IPO Year
  • BEAM 2020
  • ALHC 2021
  • Fundamental
  • Price
  • BEAM $23.58
  • ALHC $12.10
  • Analyst Decision
  • BEAM Buy
  • ALHC Buy
  • Analyst Count
  • BEAM 11
  • ALHC 9
  • Target Price
  • BEAM $45.90
  • ALHC $10.63
  • AVG Volume (30 Days)
  • BEAM 1.3M
  • ALHC 2.4M
  • Earning Date
  • BEAM 11-05-2024
  • ALHC 10-29-2024
  • Dividend Yield
  • BEAM N/A
  • ALHC N/A
  • EPS Growth
  • BEAM N/A
  • ALHC N/A
  • EPS
  • BEAM N/A
  • ALHC N/A
  • Revenue
  • BEAM $349,643,000.00
  • ALHC $2,467,707,000.00
  • Revenue This Year
  • BEAM N/A
  • ALHC N/A
  • Revenue Next Year
  • BEAM $6.04
  • ALHC $29.19
  • P/E Ratio
  • BEAM N/A
  • ALHC N/A
  • Revenue Growth
  • BEAM 328.73
  • ALHC 43.47
  • 52 Week Low
  • BEAM $20.84
  • ALHC $4.46
  • 52 Week High
  • BEAM $49.50
  • ALHC $14.25
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 45.28
  • ALHC 50.39
  • Support Level
  • BEAM $23.67
  • ALHC $10.80
  • Resistance Level
  • BEAM $25.87
  • ALHC $12.24
  • Average True Range (ATR)
  • BEAM 2.23
  • ALHC 0.69
  • MACD
  • BEAM -0.24
  • ALHC -0.22
  • Stochastic Oscillator
  • BEAM 19.58
  • ALHC 37.68

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About ALHC Alignment Healthcare Inc.

Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.

Share on Social Networks: